Home

WED., MAY 10, 8AM-5PM

A day-long event tailored to Yale innovators to encourage the sharing of new discoveries and technologies with market potential with the broader investment community.

About

The Yale Innovation Summit is a day-long event tailored to Yale innovators to encourage the sharing of new discoveries and technologies with market potential with the broader investment community.

Check out the 2017 Event Program!

Held at Yale School of Management, and presented by the Office of Cooperative Research and the Yale Entrepreneurial Institute, last year’s event featured more than 350 attendees including faculty members, local industry executives, students and post-docs.  Additionally, over 50 venture capital investors were represented from over 25 firms that in aggregate had over $40 billion under management. This was the most significant gathering of venture investors ever on Yale’s campus.

CONFIRMED 2017 VC FIRMS:

5AM Ventures, Atlas Venture, Elm Street Ventures, Abbvie Ventures, Evolution Life Science Partners, F-Prime Capital Partners, Bulldog Innovation Group, Chart Venture Partners, Nyca Partners, OrbiMed, Polaris Partners, Thayer Street Partners, Vital Venture Capital, New Enterprise Associates, Oak HC/FT, New Leaf Venture Partners, Golden Seeds, Pickwick Capital Partners, Samsung Ventures, Polaris Partners, Axiom Venture Partners, Sanofi-Genzyme BioVentures, LifeSci Capital, Maverick Ventures, Eight Seven Capital, Greater Good Ventures, Trillium Medical Ventures, Blue Ivy Ventures, Fairview Capital Partners, Velocity Fund Partners, Johnson & Johnson, Novartis Venture Funds, Hercules Capital, Agent Capital, Lockheed Martin Ventures & Morningside Group

CONFIRMED 2017 PANELISTS & SPEAKERS:

  • Rob Bettigole, Managing Partner, Elm Street Ventures
  • Kevin Bitterman, Partner, Polaris Partners
  • Christine Brennan, Principal, Novartis Venture Funds
  • Erdogan Cesmeli, Executive Director, GE Ventures
  • Gerald Chan, Cofounder, Morningside Group
  • Christopher J. Denn, Partner, Goodwin
  • Jason Hafler, Senior Director of Investments, Sanofi-Genzyme BioVentures
  • Roy Herbst, Associate Director for Translational Research, Yale Cancer Center
  • Paul Hermes, Entrepreneur-in-Residence, Medtronic
  • Paul Hughes, Partner, Wiggin & Dana
  • Jim Hornthal, Chairman, M34 Capital, Zignal Labs
  • Hyuk Jeen-Suh, Head of Samsung Ventures East Coast
  • Ken Kaufmann, VP Marketing, Hamamatsu
  • Patricia Kemp, General Partner, Oak HC/FT
  • Chau Khuong, Private Equity Partner, OrbiMed
  • Stephen Knight, President and Managing Partner, F-Prime Capital Partners
  • Kathleen McGroddy-Goetz, VP, Partnerships & Solutions, IBM Watson Health
  • Chris McLeod, Managing Partner, Elm Street Ventures
  • Chris Moran, VP & GM at Lockheed Martin Ventures
  • Sara Nayeem, Partner, New Enterprise Associates
  • Lili Portilla, Director of Office Strategic Alliances, NCATS
  • Liam Ratcliffe, Managing Director, New Leaf Venture Partners
  • Jeffrey Reitman, Principal, Nyca Partners
  • Jason Rhodes, Partner, Atlas Venture
  • Helge Seetzen, General Partner, Tandem Launch
  • Stephen Squinto, Venture Partner, OrbiMed
  • Mary Tanner, Senior Managing Director, Evolution Life Science Partners
  • Lou Tartaglia, Executive-in-Residence, 5AM Ventures
  • James Tobin, Vice President, Cardiovascular and Metabolism Scientific Innovation, Johnson & Johnson
  • Jarrod Yuster, CEO, Pico Quantitative Trading

           

Yale Innovation Summit to Feature Leading Investor and Philanthropist Gerald Chan

The Yale Innovation Summit will feature Gerald Chan as a keynote speaker. Chan is the cofounder of Morningside Group—a private equity and venture capital firm that has invested in a number of biotech companies—and a noted philanthropist. He donated $350M to Harvard, his alma mater, for the renamed Harvard T.H. Chan School of Public Health—the largest such gift in the university’s history. READ MORE.

Biotech Track

The Biotech Track is aimed at those interested in commercializing ideas for drug discovery and biological therapeutics.

Tech Track

The Tech Track is aimed at those interested in commercializing ideas from the physical and computer sciences, engineering, software and services.

Schedule & Program

2017 EVENT PROGRAM HERE

YALE INNOVATION SUMMIT SCHEDULE

7-8am REGISTRATION
7:15-9am CONTINENTAL BREAKFAST
9am WELCOME TO THE YALE INNOVATION SUMMIT
9:10am KEYNOTE ADDRESS

Jim Hornthal

Founder, Launchpad

Zhang Auditorium

10am Audience for tech ventures heads upstairs
BIOTECH TRACK TECH TRACK
10:05am Biotech Venture Investors Panel

“Crossing the Chasm: from Invention to Clinical Trial Funding”

  • Rob Bettigole, Moderator (Elm Street Ventures)
  • Lili Portilla (NIH)
  • Kevin Bitterman (Polaris Partners)
  • Christine Brennan (Novartis)
  • Jason Hafler (Sanofi-Genzyme)
  • James Tobin (Johnson & Johnson)
  • Chau Khuong (OrbiMed)
  • Lou Tartaglia (5AM Ventures)

Zhang Auditorium

Tech Venture Investors Panel

“Corporate Venture Capital Investing in Technology”

  • Chris McLeod, Moderator (Elm Street Ventures)
  • Paul Hermes (Medtronic)
  • Kathleen McGroddy-Goetz (IBM Watson Health)
  • Ken Kaufmann (Hamamatsu)
  • Chris Moran (Lockheed Martin Ventures)
  • Erdogan Cesmeli (GE Ventures)

Room 2400

11am COFFEE BREAK
11:15am BIOTECH PITCH CONTEST

Biotech startups make 5-minute pitches

Zhang Auditorium

TECH PITCH CONTEST

Tech startups make 5-minute pitches

Room 2400

12:30pm LUNCH / POSTER SESSION / NETWORKING

————————————

Biotech & Tech Showcase in Zhang Auditorium (Biotech) and Room 2400 (Tech)

1:45pm FEATURED BIOTECH ADDRESS

Roy Herbst, MD

Associate Director for Translational Research, Yale Cancer Center

“The Future of Immuno-Oncology”

 

BIOTECH PANEL DISCUSSION

“The Future of Immuno-Oncology”

  • Chris Denn, Moderator (Goodwin Law)
  • Jason Rhodes (Atlas Venture)
  • Stephen Squinto (OrbiMed)
  • Mary Tanner (Evolution Life Science Partners)
  • Sara Nayeem (New Enterprise Associates)
  • Liam Ratcliffe (New Leaf Ventures)
  • Stephen Knight (F-Prime Capital Partners)
  • Roy Herbst (Yale Cancer Center)

Zhang Auditorium

 

TECH PANEL DISCUSSION

“Building Successful Ventures from Startup to Exit

  • Paul Hughes, Moderator (Wiggin & Dana)
  • Hyuk Jeen-Suh (Samsung Ventures)
  • Patricia Kemp (Oak HC/FT)
  • Jeffrey Reitman (Nyca Partners)
  • Helge Seetzen (Tandem Launch)
  • Jarrod Yuster (Pico Quantitative Trading)

Room 2400

3pm COFFEE BREAK
3:15pm KEYNOTE ADDRESS
GERALD CHAN, Cofounder, Morningside Group “Reflections on Venture Investing in Biotechnology” Zhang Auditorium
4:15pm CLOSING REMARKS / BLAVATNIK AWARD PRESENTATIONS

Peter Salovey, President of Yale

Zhang Auditorium

5pm Photos & Departure